Viewing Study NCT01942993


Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2026-01-01 @ 4:49 PM
Study NCT ID: NCT01942993
Status: TERMINATED
Last Update Posted: 2020-09-30
First Post: 2013-09-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma
Sponsor: Philip Friedlander
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GCO 13-0427
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View